Page last updated: 2024-08-18

framycetin and Lymphoma, Non-Hodgkin

framycetin has been researched along with Lymphoma, Non-Hodgkin in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	3 (75.00)	18.7374
1990's	1 (25.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
DE BRUYN, WM; HANSEN-MELANDER, E	1
EAKINS, D; FULTON, T; HADDEN, DR	1
Brenner, MK; Heslop, HE; Krance, RA; Moen, R; Roberts, WM; Rochester, R; Rooney, C; Sixbey, J; Smith, CA; Turner, V	1
Fireman, BH; Friedman, GD; Selby, JV	1

Trials

1 trial(s) available for framycetin and Lymphoma, Non-Hodgkin

Article	Year
Administration of neomycin-resistance-gene-marked EBV-specific cytotoxic T lymphocytes to recipients of mismatched-related or phenotypically similar unrelated donor marrow grafts. Human gene therapy, 1994, Volume: 5, Issue:3 Topics: Adult; Biomarkers; Bone Marrow Transplantation; Cell Line; Child; Clinical Protocols; Cytotoxicity, Immunologic; Drug Resistance; Female; Genetic Vectors; Graft vs Host Disease; Herpesviridae Infections; Herpesvirus 4, Human; Humans; Immunocompromised Host; Incidence; Informed Consent; Kanamycin Kinase; Leukemia; Lymphoma, Non-Hodgkin; Lymphoproliferative Disorders; Male; Moloney murine leukemia virus; Myelodysplastic Syndromes; Neomycin; Phosphotransferases (Alcohol Group Acceptor); Recombinant Fusion Proteins; Safety; T-Lymphocytes, Cytotoxic; Tissue Donors; Transplantation, Homologous; Tumor Virus Infections; Virus Activation	1994

Article

Year

Administration of neomycin-resistance-gene-marked EBV-specific cytotoxic T lymphocytes to recipients of mismatched-related or phenotypically similar unrelated donor marrow grafts.

Human gene therapy, 1994, Volume: 5, Issue:3

Topics: Adult; Biomarkers; Bone Marrow Transplantation; Cell Line; Child; Clinical Protocols; Cytotoxicity, Immunologic; Drug Resistance; Female; Genetic Vectors; Graft vs Host Disease; Herpesviridae Infections; Herpesvirus 4, Human; Humans; Immunocompromised Host; Incidence; Informed Consent; Kanamycin Kinase; Leukemia; Lymphoma, Non-Hodgkin; Lymphoproliferative Disorders; Male; Moloney murine leukemia virus; Myelodysplastic Syndromes; Neomycin; Phosphotransferases (Alcohol Group Acceptor); Recombinant Fusion Proteins; Safety; T-Lymphocytes, Cytotoxic; Tissue Donors; Transplantation, Homologous; Tumor Virus Infections; Virus Activation

1994

Other Studies

3 other study(ies) available for framycetin and Lymphoma, Non-Hodgkin

Article	Year
Chromosome studies in the MB mouse lymphosarcoma. Journal of the National Cancer Institute, 1962, Volume: 28 Topics: Chromosomes; Lymphoma; Lymphoma, Non-Hodgkin; Neomycin	1962
RETICULUM CELL SARCOMA OF THE SMALL BOWEL AND STEATORRHOEA. Gut, 1964, Volume: 5 Topics: Ascorbic Acid; Blood Transfusion; Body Weight; Bone Marrow Examination; Celiac Disease; Diet; Diet Therapy; Fats; Feces; Folic Acid; Humans; Intestinal Neoplasms; Intestinal Perforation; Intestine, Small; Iron; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Nandrolone; Neomycin; Neoplasms; Pathology; Prednisone; Sarcoma; Steatorrhea; Surgical Procedures, Operative; Vitamin A; Vitamin B 12; Vitamin B Complex; Vitamins; Water-Electrolyte Balance	1964
Screening prescription drugs for possible carcinogenicity: eleven to fifteen years of follow-up. Cancer research, 1989, Oct-15, Volume: 49, Issue:20 Topics: Anti-Bacterial Agents; Atropa belladonna; Carcinogens; Drug-Related Side Effects and Adverse Reactions; Erythromycin; Esophageal Neoplasms; Folic Acid; Follow-Up Studies; Gastrointestinal Neoplasms; Lung Neoplasms; Lymphoma, Non-Hodgkin; Multiple Myeloma; Neomycin; Neoplasms; Phenylbutazone; Piperidones; Plants, Medicinal; Plants, Toxic; Polymyxin B; Propantheline; Secobarbital; Sulfathiazoles; Vitamins	1989